Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 12:40PM ET
1.31
Dollar change
-0.01
Percentage change
-0.76
%
Index- P/E- EPS (ttm)- Insider Own0.89% Shs Outstand2.24M Perf Week2.34%
Market Cap2.93M Forward P/E- EPS next Y-3.16 Insider Trans0.00% Shs Float2.22M Perf Month0.00%
Income- PEG- EPS next Q- Inst Own0.07% Short Float6.23% Perf Quarter-28.02%
Sales- P/S- EPS this Y74.09% Inst Trans19.68% Short Ratio0.14 Perf Half Y-55.14%
Book/sh-0.26 P/B- EPS next Y26.15% ROA- Short Interest0.14M Perf Year-84.77%
Cash/sh0.03 P/C48.91 EPS next 5Y- ROE- 52W Range1.05 - 17.20 Perf YTD-62.36%
Dividend Est.- P/FCF- EPS past 5Y50.52% ROI- 52W High-92.38% Beta2.44
Dividend TTM- Quick Ratio0.27 Sales past 5Y-20.00% Gross Margin- 52W Low24.75% ATR (14)0.10
Dividend Ex-Date- Current Ratio0.32 EPS Y/Y TTM5.52% Oper. Margin-1363.43% RSI (14)51.97 Volatility7.60% 8.17%
Employees12 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price290.46
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q87.98% Payout- Rel Volume0.02 Prev Close1.32
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsApr 10 BMO Avg Volume974.05K Price1.31
SMA208.67% SMA50-6.25% SMA200-50.99% Trades Volume12,095 Change-0.76%
Jun-20-24 09:01AM
May-28-24 10:31AM
May-24-24 08:45AM
May-23-24 08:47AM
May-01-24 08:47AM
08:47AM Loading…
Apr-24-24 08:47AM
Apr-17-24 08:00AM
Apr-15-24 08:00AM
Apr-12-24 08:20AM
Apr-10-24 08:00AM
Apr-04-24 08:45AM
Mar-25-24 08:47AM
Feb-07-24 08:47AM
Jan-24-24 08:47AM
Jan-08-24 08:47AM
08:47AM Loading…
Dec-29-23 08:47AM
Dec-14-23 05:51AM
Dec-11-23 08:00AM
Dec-05-23 12:54PM
Nov-29-23 10:20AM
Nov-27-23 08:48AM
Nov-17-23 02:45PM
09:04AM
Nov-10-23 08:47AM
Sep-14-23 08:47AM
Sep-12-23 07:30AM
Sep-06-23 08:47AM
Aug-23-23 08:47AM
Jul-20-23 08:47AM
Jul-17-23 08:47AM
08:00AM Loading…
Jul-06-23 08:00AM
Jul-05-23 08:47AM
Jun-15-23 08:47AM
May-31-23 04:30PM
May-24-23 08:47AM
May-16-23 07:30AM
May-12-23 08:47AM
May-09-23 07:15AM
May-01-23 08:47AM
Apr-12-23 09:30AM
Apr-11-23 09:58AM
Apr-10-23 08:47AM
Mar-22-23 08:47AM
Mar-15-23 08:47AM
Mar-03-23 08:47AM
Feb-27-23 08:47AM
Feb-14-23 08:47AM
Feb-07-23 08:47AM
Jan-27-23 08:47AM
Jan-24-23 08:17AM
Jan-10-23 08:47AM
Dec-19-22 08:47AM
Dec-02-22 08:47AM
Nov-30-22 08:47AM
08:07AM
Nov-22-22 08:47AM
Nov-10-22 08:47AM
Nov-09-22 08:47AM
Nov-08-22 08:47AM
Oct-24-22 08:47AM
Oct-21-22 08:47AM
Oct-13-22 08:47AM
Oct-03-22 08:47AM
Sep-27-22 08:47AM
Sep-13-22 08:47AM
Sep-08-22 08:57AM
07:17AM
Aug-30-22 09:24AM
Aug-03-22 12:15PM
Aug-01-22 08:47AM
Jul-28-22 08:47AM
Jul-25-22 08:47AM
Jul-19-22 08:47AM
Jul-12-22 08:47AM
Jun-29-22 07:30AM
Jun-27-22 08:30AM
Jun-23-22 08:47AM
Jun-13-22 08:47AM
Jun-09-22 05:25PM
Jun-08-22 08:47AM
May-31-22 08:47AM
May-23-22 08:47AM
May-20-22 09:00AM
May-19-22 09:00AM
May-18-22 08:47AM
May-05-22 08:47AM
Apr-19-22 09:00AM
Apr-12-22 07:30AM
Apr-11-22 08:47AM
Apr-04-22 08:47AM
Mar-15-22 09:00AM
Mar-11-22 09:00AM
Mar-09-22 09:00AM
Mar-04-22 09:15AM
Feb-14-22 09:00AM
Feb-09-22 09:00AM
Feb-07-22 09:00AM
Feb-04-22 09:25AM
Jan-21-22 09:00AM
Jan-13-22 09:00AM
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.